510(k) K133600

COEUR, INC. FRONTLOAD FOR OPTIVANTAGE POWER INJECTOR by Coeur, Inc. — Product Code DXT

K133600 is an FDA 510(k) premarket notification submitted by Coeur, Inc. for the device "COEUR, INC. FRONTLOAD FOR OPTIVANTAGE POWER INJECTOR". The FDA issued a decision of Substantially Equivalent on April 30, 2014. The device falls under product code DXT (Injector And Syringe, Angiographic), a Class II device regulated under 21 CFR 870.1650. Coeur, Inc. has at least 10 other 510(k) clearances on record.

Clearance Details

Decision
SESE (Substantially Equivalent)
Decision Date
April 30, 2014
Date Received
November 25, 2013
Clearance Type
Traditional
Expedited Review
No
Third Party Review
No

Device Classification

Device Name
Injector And Syringe, Angiographic
Device Class
Class II
Regulation Number
870.1650
Review Panel
HO
Submission Type